Navidea aims to get European clearance for Lymphoseek

02/1/2012 | Business Wire

Navidea Biopharmaceuticals says it will submit a marketing authorization application in the European Union for Lymphoseek following advice from regulators that the drug qualifies for the filing. The company will pursue permission for the use of Lymphoseek in intraoperative lymphatic mapping and lymphoscintigraphy imaging.

View Full Article in:

Business Wire

Published in Brief:

SmartBrief Job Listings for Health Care